Search

Developing outcome measures for research

There are challenges in developing outcomes measures; Professor Hall presents five top pointers for making rapid progress in developing outcome measures for research purposes. Anyone who has worked clinically with hearing loss will appreciate that every patient’s experience is personal....

Hidden hearing loss in humans

Awareness of cochlear synaptopathy (‘hidden hearing loss’) is growing. Chris Plack gives us an introduction to the condition, defining it and reviewing recent research in humans and animals with respect to noise exposure. The main cause of hearing loss is...

What’s hidden in hidden hearing loss?

In order to truly understand the many key aspects of acquired sensorineural hearing loss, the role of cochlear synaptopathy or ‘hidden hearing loss’ must be considered. Dan Guo and Sharon Kujawa review and summarise what we know to date, including...

Unravelling the mystery of hyperacusis with pain

When a person says that sound causes them pain, how can we understand this, and determine what processes are involved? Bryan Pollard navigates us through what is presently known. Pain has long been underrepresented – and often, completely overlooked –...

Speech mapping and the benefits of using in clinical practice

Fitting hearing aids is not simply a case of one size fits all. Nicole da Rocha discusses the benefits of using speech mapping as a verification tool. The verification of hearing aids has become quintessential for best practice. Using either...

Understanding new and emerging categories of hearing devices

The hearing device landscape is rapidly changing, and what should be given, to whom, and why, are questions that many hearing healthcare professionals are asking. Brent Edwards discusses these questions and how consumer characteristics may influence their choice. In 2016,...

Recent changes in vestibular science and assessment

Clinical assessment of the dizzy or imbalanced patient is all about the patient’s history. History, history, history. But what about puzzling cases when we feel we need more information? Sally Rosengren gives us a rundown of the vestibular tests which...

Cognition and hearing – you can’t test one with the other!

Cognitive Psychologist, Boaz M Ben-David, provides insights into the import of considering cognitive factors when assessing speech perception ability to maximise intervention success. Failing to do so, he suggests, is “ageist”, a predisposition healthcare professionals must avoid. Cognitive performance is...

Innovative approaches to treating deafness

Shahar Taiber and Karen Avraham give us a summary of gene therapies for hearing loss, with an overview of limitations and what the future holds. Hearing loss is the most common sensory disorder. The last two decades have seen a...

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.

The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies

Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...